Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia

6Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations. Copyright © 2012, American Society for Microbiology.

Cite

CITATION STYLE

APA

Van Mens, S. P., Meijvis, S. C. A., Grutters, J. C., Vlaminckx, B. J. M., Bos, W. J. W., & Rijkers, G. T. (2012). Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia. Clinical and Vaccine Immunology, 19(5), 811–813. https://doi.org/10.1128/CVI.05697-11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free